These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

158 related items for PubMed ID: 9808564

  • 21. Six amino acid residues in a 1200 Å2 interface mediate binding of factor VIII to an IgG4κ inhibitory antibody.
    Lin JC, Ettinger RA, Schuman JT, Zhang AH, Wamiq-Adhami M, Nguyen PC, Nakaya-Fletcher SM, Puranik K, Thompson AR, Pratt KP.
    PLoS One; 2015; 10(1):e0116577. PubMed ID: 25615825
    [Abstract] [Full Text] [Related]

  • 22. New characteristics of anti-factor VIII inhibitor antibody epitopes and unusual immune responses to Factor VIII.
    Scandella D.
    Semin Thromb Hemost; 2002 Jun; 28(3):291-6. PubMed ID: 12098091
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Relationship between the binding sites for von Willebrand factor, phospholipid, and human factor VIII C2 inhibitor alloantibodies within the factor VIII C2 domain.
    Nogami K, Shima M, Giddings JC, Takeyama M, Tanaka I, Yoshioka A.
    Int J Hematol; 2007 May; 85(4):317-22. PubMed ID: 17483075
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Identification of a factor VIII peptide, residues 2315-2330, which neutralizes human factor VIII C2 inhibitor alloantibodies: requirement of Cys2326 and Glu2327 for maximum effect.
    Nogami K, Shima M, Nakai H, Tanaka I, Suzuki H, Morichika S, Shibata M, Saenko EL, Scandella D, Giddings JC, Yoshioka A.
    Br J Haematol; 1999 Oct; 107(1):196-203. PubMed ID: 10520041
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Contributions of Asn2198, Met2199, and Phe2200 in the factor VIII C2 domain to cofactor activity, phospholipid-binding, and von Willebrand factor-binding.
    Lewis DA, Pound ML, Ortel TL.
    Thromb Haemost; 2003 May; 89(5):795-802. PubMed ID: 12719775
    [Abstract] [Full Text] [Related]

  • 30. High-resolution mapping of epitopes on the C2 domain of factor VIII by analysis of point mutants using surface plasmon resonance.
    Nguyen PC, Lewis KB, Ettinger RA, Schuman JT, Lin JC, Healey JF, Meeks SL, Lollar P, Pratt KP.
    Blood; 2014 Apr 24; 123(17):2732-9. PubMed ID: 24591205
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. A human FVIII inhibitor modulates FVIII surface electrostatics at a VWF-binding site distant from its epitope.
    Dimitrov JD, Roumenina LT, Plantier JL, Andre S, Saboulard D, Meslier Y, Planchais C, Jacquemin M, Saint-Remy JM, Atanasov BP, Kaveri SV, Lacroix-Desmazes S.
    J Thromb Haemost; 2010 Jul 24; 8(7):1524-31. PubMed ID: 20374449
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Discontinuous epitopes on the C2 domain of coagulation Factor VIII mapped by computer-designed synthetic peptides.
    Lebreton A, Moreau V, Lapalud P, Cayzac C, André S, Nguyen C, Schved JF, Lavigne G, Granier C.
    Br J Haematol; 2011 Nov 24; 155(4):487-97. PubMed ID: 21933172
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Hybrid human-porcine factor VIII proteins partially escape the inhibitory effects of anti-factor VIII inhibitor alloantibodies having A2 or C2 domain specificity.
    Mizumachi K, Nakajima Y, Shimonishi N, Furukawa S, Ogiwara K, Takeyama M, Nogami K.
    Haemophilia; 2024 Jan 24; 30(1):140-150. PubMed ID: 38058226
    [Abstract] [Full Text] [Related]

  • 39. Epitope mapping via selection of anti-FVIII antibody-specific phage-presented peptide ligands that mimic the antibody binding sites.
    Kahle J, Orlowski A, Stichel D, Becker-Peters K, Kabiri A, Healey JF, Brettschneider K, Naumann A, Scherger AK, Lollar P, Schwabe D, Königs C.
    Thromb Haemost; 2015 Feb 24; 113(2):396-405. PubMed ID: 25520269
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.